Trial Profile
Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain Measured by Functional MRI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2017
Price :
$35
*
At a glance
- Drugs Lixisenatide (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 27 Nov 2017 Status changed from recruiting to completed.
- 26 Apr 2016 New trial record